Navigation Links
Savient Submits Biologics License Application (BLA) for pegloticase
Date:10/31/2008

enrollment was completed in March 2007; and the Phase 3 clinical studies were completed in October 2007 and the BLA was filed with the FDA in October 2008. Savient has exclusively licensed worldwide rights to the technology related to pegloticase, formerly referred to as Puricase(R), from Duke University and Mountain View Pharmaceuticals, Inc. Savient's experienced management team is committed to advancing its pipeline and expanding its product portfolio by in-licensing late-stage compounds and exploring co-promotion and co-development opportunities that fit the Company's expertise in specialty pharmaceuticals and biopharmaceuticals with an initial focus in rheumatology. Savient also manufactures and supplies Oxandrin(R) (oxandrolone tablets, USP) CIII in the U.S. Puricase is a registered trademark of Mountain View Pharmaceuticals, Inc. Further information on Savient can be accessed by visiting: http://www.savient.com.

FORWARD-LOOKING LANGUAGE

We may from time to time make written or oral forward-looking statements, including statements contained herein, in our filings with the Securities and Exchange Commission, in our press releases and in our reports to stockholders within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts included in this press release regarding our strategy, strategic alliances, competitive position, plans and objectives of management are forward-looking statements that are subject to certain risks, trends and uncertainties that could cause actual results and achievements to differ materially from those expressed in such statements. These risks, trends and uncertainties are in some instances beyond our control. Words such as "anticipate," "believe," "estimate," "expect," "intend," "plan," "will" and other similar expressions help identify forward-looking statements, although not all forward-looking statemen
'/>"/>

SOURCE Savient Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Savient Pharmaceuticals to Hold Third Quarter 2008 Financial Results Conference Call on Thursday, November 6, 2008
2. Savients Pegloticase Data in Treatment-Failure Gout Patients Presented at 72nd Annual Meeting of the American College of Rheumatology Conference
3. Exelixis Submits XL880 Diligence Report to GlaxoSmithKline
4. Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia
5. CV Therapeutics Submits Supplemental New Drug Application for Ranexa(R) (ranolazine extended-release tablets)
6. AMDL Submits Data to FDA for Clearance to Market Its DR-70(R) Diagnostic Test to Monitor Colorectal Cancer Patients
7. Cephalon Submits Supplemental New Drug Application for FENTORA
8. Angiotech Submits 510(K) To FDA For Its Innovative 5-FU CVC
9. Exelixis Submits XL139 Diligence Report to Bristol-Myers Squibb
10. Cephalon Submits New Drug Application for TREANDA for the Treatment of Patients with Relapsed Indolent Non-Hodgkins Lymphoma
11. MedImmune Submits Biologics License Application to FDA for Motavizumab
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... Basel, Switzerland (PRWEB) May 22, 2013 ... solutions for industrial biotechnology, drug discovery, and life ... Genedata Selector ™ as its bioinformatics ... its production-relevant organisms. Genedata will provide AB Enzymes, ... manufacturers, with a hosted solution of Genedata Selector ...
(Date:5/22/2013)... May 22, 2013 AudioNotch ... therapy for tinnitus treatment. AudioNotch is pleased to ... With clinic locations in both British Columbia and ... audiology and hearing services. AudioNotch's tinnitus treatment program ... Upon entering a Destination Hearing clinic, patients have ...
(Date:5/22/2013)... (PRWEB) May 22, 2013 Express ... Supplies Pty Ltd are pleased to announce a ... the Australian and New Zealand distributor of DrugCheck® onsite ... Supercar Team participated in the Austin 400 May 17-19 ... into an agreement that involves each car of the ...
(Date:5/22/2013)... Envera announced today that Michael McErlean ... McErlean has an extensive background in cell production and ... career. , Mike Matheny, President and Owner ... Mike join our team”. “Mike’s background is perfectly suited ... and downstream processing equipment”, added Matheny. “Mike’s hands ...
Breaking Biology Technology:AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization 2AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization 3AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization 4AudioNotch Tinnitus Treatment Launches Partnership With Destination Hearing 2Australian Distributor of Express Diagnostics Signs Sponsorship Agreement with V8 Supercar Team 2Envera Appoints Michael McErlean Fermentation Manager 2
... depend on lasers. But when information is transmitted down ... clear enough to be decoded at the other end. ... of the light, otherwise known as the wavelength, and ... A team from EPFL and the Swiss Federal Laboratories ...
... 2011 "Hello Truth" has meaning for Robert McClendon, DDC,s ... was freed through forensic DNA testing in 2008. Even more so ... of DDC,s newly named DNA analyzer, "Hello Truth," in honor ... to the surprise unveiling, McClendon recounted his first-person story to the ...
... April 12, 2011 Water Street Healthcare Partners ... health care, announced today that Scott Garrett has joined ... the former chairman, president and chief executive officer of ... 35 years of experience leading health care businesses ranging ...
Cached Biology Technology:Better lasers for optical communications 2DNA Analyzer "Hello Truth" Unveiled During Innocence Network International Delegate Tour of DDC 2DNA Analyzer "Hello Truth" Unveiled During Innocence Network International Delegate Tour of DDC 3Scott Garrett Joins Water Street Healthcare Partners 2Scott Garrett Joins Water Street Healthcare Partners 3
(Date:5/22/2013)... in a major new effort to educate the public ... people with clean water that looms ahead in the ... in the current edition of Chemical & Engineering ... Society (ACS), the world,s largest scientific society. , Bassam ... L. Schnoor, Ph.D., explain that shortages of reliable supplies ...
(Date:5/22/2013)... The feared Legionella pneumophila bacteria is responsible ... pneumonia. In order to infect us, this pathogen has ... and go unnoticed in our cells, thus avoiding these ... the Basque biosciences research centre, CIC bioGUNE, in which ... the USA and the National Supercomputation Centre in Barcelona ...
(Date:5/21/2013)... for a long time that some creatures evolve more ... for plants. But it may be that height plays ... and the U. S. National Evolutionary Synthesis Center. ... in the journal Nature Communications , Lanfear and ... Drawing from a database of global patterns in plant ...
Breaking Biology News(10 mins):Mechanism discovered which aids Legionella to camouflage itself in the organism 2Small but speedy: Short plants live in the evolutionary fast lane 2
... Spanish . Obese men should consider ... told the 24th annual conference of the European Society of ... Ghiyath Shayeb, from the University of Aberdeen, Aberdeen, UK, said ... body mass index (BMI) had lower volumes of seminal fluid ...
... Inc., (OTC,Bulletin Board: BMRX), today announced that it ... former competitor, Sequiam Corporation. The company also,announced that ... into the,company,s technology portfolio and consumer based biometric ... the company,s smartTOUCH,brand., The purchase price paid ...
... Lauderdale, FL (July 8, 2008) Scientists announced today ... size of the Southern Atlantic Ocean,s largest and richest ... of Brazil,s Bahia state. The newly discovered ... than the previously known Abrolhos reef system, one of ...
Cached Biology News:Obese men have less semen, more sperm abnormalities, and should lose weight before trying for a baby 2bioMETRX, Inc. Completes Sequiam Asset Purchase 2Scientists discover new reefs teeming with marine life in Brazil 2
Request Info...
... qualitatively detect EGFR gene ... (FFPE) tissue sections, metaphase ... preparations, using Chromogenic In ... In Situ Hybridization (FISH) ...
Request Info...
Many mammalian cell types and experimental situations create challenges for standard transfection experiments. The ViraPower Lentiviral Expression System overcomes these challenges with efficient vir...
Biology Products: